Related Experiment Video
Updated: Jun 2, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
[Pharmacokinetics and tissue distribution of long circulating liposomes in rabbits and mice]
1Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Objective:
To investigate the pharmacokinetic profiles and tissue distribution of long circulating liposome formulations-anionic, cationic, and neutral long circulating liposomes (NA, PA, A-D) in rabbits and mice.
Methods:
Conventional liposomes (CA) encapsulated with 125I-bcl-2/bcl-xl ASON and free 125I-bcl-2/bcl-xl ASON (FA) were intravenously administered to rabbits and mice. The blood samples from rabbits and organs from mice were collected, respectively. The radioactivity of the blood and tissues samples were measured.
Results:
The clearance of the four kinds of liposomes and FA exhibited bicompartmental behaviors. Compared with others, NA demonstrated favourable pharmacokinetic properties characterized with enhancement of T9(1/2 alpha) and T(1/2 beta), increased area under concentration-time curve, and decreased liver uptake. Higher uptake in the liver, spleen and kidney of mice and lower uptake in the brain, muscle, and bone of mice were observed shortly after intravenous injection of the four different kinds of liposomes and FA. A 30% decrease in uptake of NA was found in the liver of mice four hours after intravenous injection compared with the uptake of CA. No significant differences were found in the uptake of the four kinds of liposomes in the spleen of mice (P > 0.05).
Conclusion:
NA is promising as a carrier for radio-antisense therapy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Distribution: Tissue Binding
For...
Factors Affecting Drug Distribution: Organ Perfusion Rate
Perfusion rate-limited distribution relies on the...
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Measurement of Bioavailability: Pharmacokinetic Methods
Bioavailability Study Design: Single Versus Multiple Dose Studies

